For Immediate Release
Chicago, IL –November 25, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Alteryx Inc. (AYX - Free Report) , Moderna Inc. (MRNA - Free Report) , America's Car-Mart Inc. (CRMT - Free Report) , Bloom Energy Corp. (BE - Free Report) and Target Corp. (TGT - Free Report) .
Here are highlights from Friday’s Analyst Blog:
5 Top Stocks that Surged Amid Volatility in the Last Week
U.S. stocks have had an impressive rally so far in 2019. All three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — are currently at striking distance from their all-time highs, which they achieved in the first half of November. However, volatility has gripped Wall Street since the past week owing to several conflicting news about the signing of an interim trade deal between the United States and China.
Meanwhile, despite stock market fluctuation on an almost regular basis, several stocks popped in the last seven trading sessions. Some of them carry a favorable Zacks Rank and have strong growth potential for the rest of this year.
Volatility is Back in Wall Street
In spite of a highly impressive rally so far in 2019, Wall Street was never completely free from market fluctuations. Volatility showed its ugly face in short spans several times this year. Lingering trade-related conflict with China, whih resulted in economic slowdown in both the United States and globally, yield curve inversion of government bonds, and geopolitical crisis in the U.K., Italy, Iran, Saudi Arabia and Venezuela also led to market fluctuations.
The latest downtrend started since the beginning of the past week, following news regarding uncertainty over the signing of a U.S.-China partial trade deal. On Nov 21, the Dow declined 0.2%, marking its third straight day of loss, its longest losing streak since August. The S&P 500 also recorded three consecutive days of losses for the first time since September. Meanwhile, the Nasdaq Composite finished in negative territory for two successive days.
Uncertainty About Partial Trade Deal
On Nov 20, Reuters reported citing people close to the White House that completion of a “phase one” U.S.-China trade deal could be delayed till next year. The Wall Street Journal also reported that the Trump administration’s desire to sign a partial trade deal with China may not be fruitful this year citing former administration officials and others sources in the White House.
On Nov 21, The Wall Street Journal reported that Chinese Vice Premier Liu He invited U.S. Trade Representative Robert Lighthizer and Treasury Secretary Steven Mnuchin to Beijing for further negotiations. Notably, Liu He is the chief trade negotiator for China. However, it is not clear whether the U.S. government will accept this invitation.
Meanwhile, on Nov 19, Trump has threatened to hike the existing tariff rate to 30% from 25% on $250 billion Chinese goods and impose tariff of $160 billion on fresh Chinese goods if the trade deal is not signed by mid-December.
Our Top Picks
At this stage, we have narrowed down our search to five stocks that popped in the past seven trading sessions and still have strong growth potential. Our picks carry either a Zacks Rank #1 (Strong Buy) or 2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Alteryx Inc.operates a self-service data analytics software platform that enables organizations to enhance business outcomes and the productivity of their business analysts, data scientists, and citizen data scientists worldwide.
The Zacks Rank #1 company has an expected earnings growth rate of 3,000% for the current year. The Zacks Consensus Estimate for the current year has moved up 20.8% over the last 30 days. The stock has surged 13.9% in the past seven days.
Moderna Inc.a clinical stage biotechnology company that develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases.
The Zacks Rank #1 company has an expected earnings growth rate of 68.9% for the current year. The Zacks Consensus Estimate for the current year has moved up 5.5% over the last 30 days. The stock has rallied 10.6% in the past seven days.
America's Car-Mart Inc. operates automotive dealerships and is one of the largest automotive retailers in the United States focused exclusively on the Buy Here/Pay Here segment of the used car market.
The Zacks Rank #2 company has an expected earnings growth rate of 22.3% for the current year. The Zacks Consensus Estimate for the current year has moved up 0.9% over the last 30 days. The stock has climbed 13.8% in the past seven days.
Bloom Energy Corp.generates and distributes renewable energy. It supplies electricity to the residential, commercial and industrial sectors. It offers a stationary power generation platform that converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion.
The Zacks Rank #2 company has an expected earnings growth rate of 54% for the current year. The Zacks Consensus Estimate for the current year has moved up 0.1% over the last 30 days. The stock has jumped 23% in the past seven days.
Target Corp.operates as a general merchandise retailer in the United States. It offers beauty and household essentials; food assortments, including perishables, dry grocery, dairy, and frozen items; and apparel, accessories, home décor products, electronics, toys, seasonal offerings, and other merchandise.
The Zacks Rank #2 company has an expected earnings growth rate of 14.5% for the current year. The Zacks Consensus Estimate for the current year has moved up 0.3% over the last 30 days. The stock has soared 16.4% in the past seven days.
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.